Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Jul;32(7):3024-3031.
doi: 10.1007/s00464-017-6011-1. Epub 2018 Jan 8.

15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures

Affiliations
Comparative Study

15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures

Nawaf Alkhalifah et al. Surg Endosc. 2018 Jul.

Abstract

Background: Laparoscopic single anastomosis (mini-)gastric bypass (LSAGB) has been validated as a safe and effective treatment for morbid obesity. However, data of the long-term outcome remain lacking.

Methods: Between October 2001 and December 2015, 1731 morbidly obese patients who received LSAGB as primary bariatric procedure at the Min-Sheng General Hospital were recruited. Surgical outcome, weight loss, resolution of comorbidities, and late complications were followed, then compared with groups of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG). All data derived from a prospective bariatric database and a retrospective analysis were conducted.

Results: The average patient age was 33.8 ± 10.4 years with a mean body mass index (BMI) of 40.4 ± 7.7 kg/m2. Of them, 70.0% were female while 30.0% were male. Mean operating time, intraoperative blood, and hospital stay of LSAGB were 124.6 ± 38.8 min, 39.5 ± 38.7 ml, and 5.0 ± 4.1 days, respectively. The 30-day post-operative major complication occurred in 30 (1.7%) of LSAGB patients, 16 (2.0%) of LRYGB, and 15 (1.4%) of LSG patients. The follow-up rates at 1, 5, and 10 years were 89.3, 52.1, and 43.6%, respectively. At postoperative 1, 5, and 10 years, the mean percentage of weight loss (%WL) of LSAGB patients were 32.7, 32.2, and 29.1%, and mean BMI became 27, 26.9, and 27 kg/m2, respectively. The LSAGB had a higher weight loss than LRYGB and LSG at 2-6 years after surgery. LSG had a lower remission rate in dyslipidemia comparing to LSAGB and LRYGB. The overall revision rate of LSAGB is 4.0% (70/1731) which was lower than the 5.1% in LRYGB and 5.2% in the LSG.

Conclusion: LSAGB is an effective procedure for treating morbid obesity and metabolic disorders, which results in sustained weight loss and a high resolution of comorbidities.

Keywords: Bariatric surgery; Comorbidities; Complications; Long term; Single anastomosis gastric bypass; Weight loss.

PubMed Disclaimer

References

    1. Obes Surg. 2016 Sep;26(9):2029-2034 - PubMed
    1. Obes Surg. 2014 Oct;24(10):1749-56 - PubMed
    1. Obes Surg. 2016 May;26(5):926-32 - PubMed
    1. Surg Obes Relat Dis. 2015 Mar-Apr;11(2):321-6 - PubMed
    1. Obes Surg. 2001 Jun;11(3):276-80 - PubMed

Publication types

LinkOut - more resources